AC Immune Ltd (ACIU) — Cash Flow-to-Debt Ratio
AC Immune Ltd (ACIU) has a Cash Flow-to-Debt Ratio of -0.15x as of December 2025, meaning its operating cash flow of $-16.45 Million could theoretically repay 0% of its total liabilities ($109.49 Million) in one year. See AC Immune Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
AC Immune Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for AC Immune Ltd across 13 annual periods. For the full cash flow conversion analysis, see AC Immune Ltd cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for AC Immune Ltd (2013–2025)
Year-by-year debt coverage analysis for AC Immune Ltd. Check AC Immune Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.60x | $-66.15 Million | $109.49 Million | ▼ -208.9% |
| 2024 | 0.55x | $65.84 Million | $118.64 Million | ▲ +120.4% |
| 2023 | -2.72x | $-60.41 Million | $22.17 Million | ▲ +37.2% |
| 2022 | -4.34x | $-73.57 Million | $16.95 Million | ▼ -94.7% |
| 2021 | -2.23x | $-65.69 Million | $29.46 Million | ▲ +12.9% |
| 2020 | -2.56x | $-59.52 Million | $23.26 Million | ▼ -224.2% |
| 2019 | 2.06x | $55.22 Million | $26.81 Million | ▲ +188.5% |
| 2018 | -2.33x | $-44.08 Million | $18.93 Million | ▼ -59.9% |
| 2017 | -1.46x | $-22.09 Million | $15.17 Million | ▼ -253.8% |
| 2016 | -0.41x | $-5.65 Million | $13.72 Million | ▼ -108.3% |
| 2015 | 4.96x | $44.08 Million | $8.89 Million | ▲ +292.2% |
| 2014 | -2.58x | $-17.62 Million | $6.83 Million | ▼ -2.8% |
| 2013 | -2.51x | $-19.80 Million | $7.89 Million | — |